The Biden administration seeks input on guardrails for open-source AI models, which encourage cooperation and innovation. These models are difficult ...
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Investigation reveals significant delays in processing complaints against UK drug companies, raising concerns about patient safety and public health. Increased ...